Omega-3 fatty acids/Vitamin E behave synergistically on adiponectin receptor-1 and adiponectin receptor-2 gene expressions in peripheral blood mononuclear cell of coronary artery disease patients

Current Topics in Nutraceutical Research

Volumn 13, Issue 1, 2015, Pages 23-32

  Ramezani, Atena ^a   Djazayeri, Abolghasem ^a   Koohdani, Fariba ^a   Nematipour, Ebrahim ^b   Javanbakht, Mohammad Hassan ^a   Keshavarz, Seyed Ali ^a   Golalizadeh, Ezzattolkh ^c   Fard, Ramin Mazaheri Nezhad ^d   Djalali, Mahmoud ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

AdipoR2; AdipoRl; Coronary artery disease; HsCRP; Omega 3 fatty acids; Vitamin E

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ALPHA TOCOPHEROL; C REACTIVE PROTEIN; CREATININE; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIETARY INTAKE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FAT INTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION;

EID: 84956689372     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. World Health Organization, Cardiovascular Diseases (CVDs) FactSheet. (2011); Available from: http://wwwwhoint/mediacentre/factsheets/fs317/en/indexhtml.
2. Alberti, L., Gilardini, L., Girola, A., Moro, M., Cavagnini, F., Invitti, C. (2007) Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes, Obesity and Metabolism 9:344-349.
3. Antoniades, C., Antonopoulos, A. S., Tousoulis, D., Stefanadis, C. (2009) Adiponectin: from obesity to cardiovascular disease. obesity reviews 10, 269-279.
4. Aprahamian, T. R., and Sam, F. (2011) Adiponectin in cardiovascular inflammation and obesity. International Journal of Inflammation 2011, 1-8.
5. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. (1999) Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257, 79-83.
6. Bacci, S., Menzaghi, C, Ercolino, T., Rauseo, A., Salvemini, L., Vigna, C., et al. (2004) The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 27, 2015-2020.
7. Bjursell, M., Ahnmark, A., Bohlooly Y, M., William-Olsson, L., Rhedin, M., Peng, X. R., et al. (2007) Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56, 583-593.
8. Fakhrzadeh, H., Larijani, B., Bandarian, F., Adibi, H., Samavat, T., Malekafzal, H., et al. (2005) The relationship between ischemic heart disease and coronary risk factors in population aged over 25 in Qazvin: A population-based study. Journal of Qazvin University of Medical Sciences 9, 26-34.
9. Gaziano, T. A. (2005). Cardiovascular Disease in the Developing World and Its Cost-Effective Management. Circulation 112, 3547-3553.
10. Gray, B., Swick, J., Ronnenberg, A. G. (2011) Vitamin E and adiponectin: proposed mechanism for vitamin E-induced improvement in insulin sensitivity. Nutrition Reviews 69, 155-161.
11. Halvatsiotis, I., Tsiotra, P. C., Ikonomidis, I., Kollias, A., Mitrou, P., Maratou, E., et al. (2010). Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes. Cardiovascular Diabetology 9, 1-11.
12. Han, S. H., Quon, M. J., Kim, J., Koh, K. K. (2007) Adiponectin and cardiovascular disease: response to therapeutic interventions. Journal ofthe American College of Cardiology 49, 531-538.
13. Hopkins, T. A., Ouchi, N., Shibata, R. and Walsh, K. (2007) Adiponectin actions in the cardiovascular system. Cardiovascular Research 74, 11-18.
14. Hotta, K., Funahashi, T., Arita, Y., et al. (2000). Plasma concentrations of a novel adipose-specific protein, adiponectin, m type 2 diabetic patients. Arteriosclerosis, Thorombosis, and Vascular Biology 20, 1595-1599.
15. Itoh, M., Suganami, T., Satoh, N., Tanimoto-Koyama, K., Yuan, X., Tanaka, K., et al. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 27, 1918-1925.
16. Iwaki, M., Matsuda, M., Maeda, N., Funahashi, T., Matsuzawa, Y., Makishima, M. et al. (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 1655-1663.
17. Jin, J., Peng, D., Yuan, S., Zhao, S., Ning, X., Wang, S., et al. (2010). Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clinica Chimica Acta 411, 1761-1765.
18. Kratz, M., Swarbrick, M. M., Callahan, H. S., Matthys, C. C., Havel, P. J., Weigle, D. S. (2008) Effect of dietary n-3 polyunsaturated fatty acids on plasma total and highmolecular-weight adiponectin concentrations in overweight to moderately obese men and women. The American Journal of Clinical Nutrition 87, 347-353.
19. Kris-Etherton, P. M., Harris, W. S., Appel, L. J. (2003) Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 23, 151-152.
20. Lau, W. B., Tao, L., Wang, Y., Li, R., Ma. X. L. (2011). Systemic adiponectin malfunction as a risk factor for cardiovascular disease. Antioxidants & Redox Signaling 15, 1863-1873.
21. Lavie, C. J., Milani, R. V., Mehra, M. R., Ventura, H. O. (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Journal of the American College of Cardiology 54, 585-594.
22. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Et al (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 8, 731-737.
23. Makhoul, Z., Kristal, A. R., Gulati, R., Luick, B., Bersamin. A., Boyer, B., et al. (2010) Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. The American Journal of Clinical Nutrition 91, 777-785.
24. Matsubara, M., Maruoka, S., Katayose, S. (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. The Journal of Clinical Endocrinology & Metabolism 87, 2764-2769.
25. Mori, T. A., Burke, V., Puddey, LB., et al. (2009). The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. Journal of Hypertension 27, 1863-1872.
26. Nakamura, Y, Shimada, K., Fukuda, D., Shimada, Y., Ehara, S., Hirose, M., et al. (2004) Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90, 528-533.
27. Ouchi, N., Kihara, S., Arita, Y., et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476.
28. Ouchi, N., Kihara, S., Arita, Y, et al. (2001) Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocytederived macrophages. Circulation 103, 1057-1063.
29. Ouchi, N., Kihara, S., Funahashi, T., Tadashi, N., Makoto, N., et al. (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107, 671-674.
30. Ouchi, N., Parker, J. L., Lugus, J. J., Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 11, 85-97.
31. Siitonen, N., Pulkkinen, L., Lindstrom, J., et al. (2011) Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaited glucose tolerance: the Finnish Diabetes Prevention Study. Cardiovascular Diabetology 10, 1-11.
32. Soccio, T., Zhang, YY., Bacci, S., Mlynarski, W., Placha, G., Raggio, G., et al. (2006) Common haplotypes at the adiponectin receptor 1 (ADIPOR1) locus are associated with increased risk of coronary artery disease in type 2 diabetes. Diabetes 55, 2763-2770.
33. Van Berendoncks, A. M., Conraads, V. M. (2011) Functional adiponectin resistance and exercise intolerance in heart failure. Current Heart Failure Reports 8, 113-122.
34. Wang, H., Zhang, H., Jia, Y., Zhang, Z., Craig, R., Wang, X., et al. (2004) Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance. Diabetes 53, 2132-2136.
35. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa. T., Iwabu, M., et al. (2007) Targeted disruption of AdipoRl and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Medicine 13, 332-339.
36. Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96, 1723-1732